Amgen Inc.

The momentum for this stock is not very good. Amgen Inc. is not very popular among insiders. Amgen Inc. is a mediocre stock to choose.
Log in to see more information.
Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture and...

News

Amgen Inc. (NASDAQ:AMGN) Shares Bought by Angeles Wealth Management LLC
Amgen Inc. (NASDAQ:AMGN) Shares Bought by Angeles Wealth Management LLC

Ticker Report Angeles Wealth Management LLC boosted its stake in shares of Amgen Inc. (NASDAQ:AMGN - Free Report) by 12.3% during the 2nd quarter, according to the company in its most recent filing with the...\n more…

Acadian Asset Management LLC Has $4.66 Million Stake in Amgen Inc. (NASDAQ:AMGN)
Acadian Asset Management LLC Has $4.66 Million Stake in Amgen Inc. (NASDAQ:AMGN)

Zolmax Acadian Asset Management LLC reduced its stake in shares of Amgen Inc. (NASDAQ:AMGN - Free Report) by 13.4% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and...\n more…

Acadian Asset Management LLC Has $4.66 Million Stake in Amgen Inc. (NASDAQ:AMGN)
Acadian Asset Management LLC Has $4.66 Million Stake in Amgen Inc. (NASDAQ:AMGN)

Ticker Report Acadian Asset Management LLC decreased its holdings in Amgen Inc. (NASDAQ:AMGN - Free Report) by 13.4% during the second quarter, according to its most recent filing with the Securities and Exchange...\n more…

Strategic Financial Concepts LLC Takes $26,000 Position in Amgen Inc. (NASDAQ:AMGN)
Strategic Financial Concepts LLC Takes $26,000 Position in Amgen Inc. (NASDAQ:AMGN)

Ticker Report Strategic Financial Concepts LLC acquired a new position in Amgen Inc. (NASDAQ:AMGN - Free Report) in the second quarter, according to the company in its most recent Form 13F filing with the...\n more…

Amgen Inc. (NASDAQ:AMGN) Shares Bought by Lantz Financial LLC
Amgen Inc. (NASDAQ:AMGN) Shares Bought by Lantz Financial LLC

Ticker Report Lantz Financial LLC lifted its position in shares of Amgen Inc. (NASDAQ:AMGN - Free Report) by 5.1% in the second quarter, according to its most recent 13F filing with the SEC. The firm owned 1,779...\n more…

Why Amgen (AMGN) Outpaced the Stock Market Today
Why Amgen (AMGN) Outpaced the Stock Market Today

Zacks Investment Research In the latest market close, Amgen (AMGN) reached $328.93, with a +0.92% movement compared to the previous day. This move outpaced the S&P 500's daily gain of 0.45%. Elsewhere, the Dow lost 0.23...\n more…